Neoplasia/BPH

	A Systematic Review and Meta-Analysis of the Significance of Diabetes on Kidney Cancer Outcomes and the Role of Metformin. Clin Genitourin Cancer Kim LH, Tai JY, Li T, Hayler R, Wang H, Lau HM, Pleass H, Nair-Shalliker V, Smith D, Patel MI. PMID: 41856872 [PubMed - as supplied by publisher]
	Urothelial Carcinoma of the Bladder Following BK Virus Infection in a Pediatric Kidney Transplant Recipient. Pediatr Transplant Ichas M, Allard L, Harper L, Yacoub M, Madden I, Vérité C, Godron-Dubrasquet A, Harambat J. PMID: 41856782 [PubMed - indexed for MEDLINE]
	Editorial Comment on "Mental Health Burden of a Testicular Cancer Diagnosis: Insights from a Large Claims Database". Urology Langston DM. PMID: 41856376 [PubMed - as supplied by publisher]
	Editorial Commentary: "Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging Treatment Era: A Patient Preference Study. Urology Smelser WW. PMID: 41856374 [PubMed - as supplied by publisher]
	Therapeutic Impact of 18F-PSMA-1007 PET/MRI in staging Intermediate/ High-Risk Prostate Cancer Patients: Imaging Biomarkers and Radiomic Analysis Associated with Tumor Aggressiveness. Rev Esp Med Nucl Imagen Mol (Engl Ed) Garcia JR, Pinilla L, Compte A, Garrido N, Mont-Castro LL, Ruiz S, Garcia Magro J, Santabárbara JM, Tovar D, Mourelo S, Soria M, Riera E. PMID: 41856314 [PubMed - as supplied by publisher]
	Frailty in older adults with cancer: A systematic review of evidence in colorectal, lung, prostate, and hematological malignancies. Rev Esp Geriatr Gerontol Bermejo Boixareu C, Martínez-Velilla N, Neira Álvarez M, Rodriguez-Couso M, Ramírez-Martín R, Mauleón-Ladrero C, González-Senac NM, Hormigo Sánchez AI, Tarazona-Santabalbina FJ, Martínez Peromingo FJ, Abizanda Soler P, Serra Rexach JA, Rodríguez Mañas L. PMID: 41855955 [PubMed - as supplied by publisher]
	Survival modelling of relapse-free survival and competing-risk analysis in patients with high-risk localized prostate cancer treated in GETUG-12. Eur J Cancer Vicier C, Erdogan F, Allouache N, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houede N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon F, Gross-Goupil M, Cojean-Zelek I, Oudard S, Labourey JL, Chinet-Charrot P, Legouffe E, Lagrange JL, Linassier C, Deplanque G, Beuzeboc P, Davin JL, Brihoum M, Culine S, Fizazi K, Le Teuff G. PMID: 41855781 [PubMed - as supplied by publisher]
	Association between biochemical and histopathological parameters in the clinical assessment of prostate tumors in a resource-limited setting in northern Cameroon. Cancer Treat Res Commun Tagne Simo R, Nodjia LP, Nwabo Kamdje AH, Ahmadou M, Danki Sillong F, Telefo PB. PMID: 41855628 [PubMed - as supplied by publisher]
	ProCausal-WS: Weakly Supervised Causal Representation Learning Driven Interpretable Prostate Cancer Diagnosis. IEEE J Biomed Health Inform Kong W, Liu W, Du H. PMID: 41855066 [PubMed - as supplied by publisher]
	Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI. J Appl Clin Med Phys Do DD, Conlin CC, Bagrodia A, Cooperberg M, Hahn ME, Harisinghani M, Hollenberg G, Javier-Desloges J, Kamran SC, Kane CJ, Lee KL, Liss MA, Margolis DJA, Murphy PM, Nakrour N, Ohliger MA, Osinski T, Rakow-Penner R, Domingo MR, Salmasi A, Shabaik AS, Song Y, Trecarten S, Wehrli N, Weinberg EP, Woolen S, Dale AM, Seibert TM. PMID: 41854856 [PubMed - indexed for MEDLINE]
	Novel radiopharmaceuticals for bladder cancer evaluation. Q J Nucl Med Mol Imaging Guglielmo P, Perrone E, Librando M, Aghaee A, Sadeghpour S, Nicolosi S, Kovic A, Mapelli P, Evangelista L. PMID: 41854639 [PubMed - as supplied by publisher]
	[The prostate biopsy during the follow-up of a cohort of 400,000 asymptomatic men undergoing PSA testing in the Agency for Health Protection of the Metropolitan Area of Milan]. Epidemiol Prev Buzzoni C, Crocetti E, Frammartino B, Cereda D, Russo AG. PMID: 41854000 [PubMed - indexed for MEDLINE]
	[Follow-up management after PSA testing in 400,000 citizens within the Agency for Health Protection of the Metropolitan Area of Milan]. Epidemiol Prev Frammartino B, Crocetti E, Buzzoni C, Cereda D, Russo AG. PMID: 41853999 [PubMed - indexed for MEDLINE]
	[Prostate cancer screening. Fragmented prevention: from prescription to diagnostic pathway]. Epidemiol Prev Russo AG. PMID: 41853996 [PubMed - in process]
	Case Report: A rare case of primary undifferentiated pleomorphic sarcoma of the renal pelvis with high PD-L1 expression and a misleading positive urine FISH. Front Immunol Li J, Wang X, Zhen J, Qi M. PMID: 41853282 [PubMed - indexed for MEDLINE]
	An efficient automated approach for accumulated dose estimation in prostate cancer radiotherapy. Phys Imaging Radiat Oncol Grohmann M, Krug D, Baehr A, Petersen C, Todorovic M, Schäfer S, Böckelmann LC, Gargioni E. PMID: 41853125 [PubMed]
	Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway. Chin J Cancer Res Wang Z, Wang J, Chen S, Wu R, Tuo Z, Ye L, Yoo KH, Li D, Jin X, Xiong W, Feng D. PMID: 41852923 [PubMed]
	Corrigendum to "Stigma experiences among young and middle-aged testicular cancer survivors in China: A phenomenological study" [Asia Pac J Oncol Nurs 13 (2026) 100825]. Asia Pac J Oncol Nurs Zhao Y, Li D, Zhang M, Yan W, Shen H, Xu M, Liu Y. PMID: 41852758 [PubMed]
	Dyadic coping, relationship quality, and psychosocial adaption between couples facing prostate cancer: A longitudinal cross-lagged study. Asia Pac J Oncol Nurs Yuan X, Chen M, Zhang T, Sun Z, Yang Z, Yin H, Yang Y. PMID: 41852754 [PubMed]
	Prognostic Significance of Radiographic Progression at Metastatic Castration-Resistant Prostate Cancer Diagnosis. Int J Urol Iwamoto H, Hori T, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Yaegashi H, Nohara T, Shigehara K, Izumi K, Mizokami A. PMID: 41852124 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 186472

Page 1 of 9324



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy